Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-25-012357
Filing Date
2025-03-12
Accepted
2025-03-12 16:24:35
Documents
4
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1741811068.html 3  
1 FORM 3 wk-form3_1741811068.xml 3 1662
2 EX-24 mdgl-poajfouse.htm EX-24 5353
3 mdgl-poajfouse001.jpg GRAPHIC 255404
4 mdgl-poajfouse002.jpg GRAPHIC 32787
  Complete submission text file 0001628280-25-012357.txt   405637
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DICK'S SPORTING GOODS 345 COURT STREET CORAOPOLIS PA 15108
Business Address
FOUSE JACQUALYN A (Reporting) CIK: 0001405288 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 25732072